Free shipping on all orders over $ 500

PIK-75 Hydrochloride

Cat. No. M1770

All AbMole products are for research use only, cannot be used for human consumption.

PIK-75 Hydrochloride Structure
Synonym:

PIK-75 HCl

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mg USD 47 In stock
25mg USD 87 In stock
50mg USD 170 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PIK-75 Hydrochloride is a PI3K p110α specific inhibitor with IC50s of 6,1300,76,510 nM for p110α,p110β,p110γ, p110δrespectively.PIK-75 is a competitive inhibitor with respect to a substrate, phosphatidylinositol (PI) in contrast to most other PI3K inhibitors, which bind at or near the ATP site.

Customer Product Validations & Biological Datas
Source Int J Oncol (2014). Figure 2. PIK-75
Method qRT-PCR
Cell Lines AsPC-1 cells
Concentrations 0.1 μM
Incubation Time 24 h
Results PIK-75 was the most potent inhibitor that reduced the ARE-Luc reporter expression upto ~50% either in the absence or presence of exogenous FLAG-NRF2
Protocol (for reference only)
Cell Experiment
Cell lines LN229:EGFR (PTENwt) and U87:EGFR (PTENmt) cells
Preparation method Cell proliferation assay and flow cytometry. For viability, 10^5 cells were seeded in 12-well plates in the presence of erlotinib, PI-103, PIK-90, rapamycin, erlotinib plus PIK-90, erlotinib plus rapamycin, erlotinib plus PIK-90, and rapamycin or erlotinib plus PI-103 for 72 h. Cell viability was determined using a WST-1 assay.
Concentrations 0, 0.1, 0.5, 1µM
Incubation time 72h
Animal Experiment
Animal models Human primary GBM43 cells female BALB/c nu/nu mice bearing xenografts model
Formulation DMSO:H20
Dosages 40 mg/kg
Administration daily i.p.
Chemical Information
Molecular Weight 488.74
Formula C16H14BrN5O4S.HCl
CAS Number 372196-77-5
Solubility (25°C) DMSO 7 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Cheng CK, et al. Proc Natl Acad Sci U S A. Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma.

[2] Zheng Z, et al. Biochem J. Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis.

[3] Fan QW, et al. Cancer Res. A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma.

Related PI3K Products
AS605240

AS-605240 is a potent and selective inhibitor of PI 3-kinase γ (PI3Kγ) with an IC50 of 8 nM.

BEZ235

BEZ235 (NVP-BEZ235) is a potent dual PI3K and mTOR inhibitor of p110α, p110γ, p110δ and p110β with IC50 of 4 nM, 5 nM, 7 nM and 75 nM, respectively.

BKM120 (Buparlisib)

BKM120 (NVP-BKM120) is a potent and highly specific oral pan-class I PI3K inhibitor.

GDC-0941 (Pictilisib)

GDC-0941 is a selective and potent inhibitor of Class I PI3K, p110a IC50=0.003uM, U87MG IC50=0.95μM.

AS-252424

AS-252424 is a furan-2-ylmethylene thiazolidinedione as a selective ATP-competitive PI3Kγ inhibitor with IC50 with 33 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: PIK-75 Hydrochloride, PIK-75 HCl supplier, PI3K, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.